Brian C. Stephenson - Feb 16, 2023 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Signature
/s/ Brian C. Stephenson
Stock symbol
BBIO
Transactions as of
Feb 16, 2023
Transactions value $
-$350,328
Form type
4
Date filed
2/21/2023, 07:16 PM
Previous filing
Feb 6, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +27.6K +12.58% 247K Feb 16, 2023 Direct F1, F2
transaction BBIO Common Stock Tax liability -$125K -9.91K -4.01% $12.64 237K Feb 16, 2023 Direct F3
transaction BBIO Common Stock Sale -$197K -15.6K -6.56% $12.65 222K Feb 17, 2023 Direct F4, F5
transaction BBIO Common Stock Sale -$28.1K -2.15K -0.97% $13.06 220K Feb 17, 2023 Direct F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -1.71K -16.67% $0.00 8.55K Feb 16, 2023 Common Stock 1.71K Direct F1, F7
transaction BBIO Restricted Stock Units Options Exercise $0 -778 -11.11% $0.00 6.23K Feb 16, 2023 Common Stock 778 Direct F1, F8
transaction BBIO Restricted Stock Units Options Exercise $0 -24.2K -20% $0.00 96.8K Feb 16, 2023 Common Stock 24.2K Direct F1, F9
transaction BBIO Restricted Stock Units Options Exercise $0 -946 -8.33% $0.00 10.4K Feb 16, 2023 Common Stock 946 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Includes 345 shares acquired by the Reporting Person on February 15, 2023 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
F3 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 27,627 shares of Common Stock underlying the Reporting Person's RSUs.
F4 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022.
F5 Represents the weighted average sale price of the shares sold from $12.04 to $13.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein.
F6 Represents the weighted average sale price of the shares sold from $13.04 to $13.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein.
F7 The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F8 The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F9 The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F10 The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.